Topics and Expertise: COVID-19

Update from the Dean: Community during challenging times

The School continues its vital work in research, education, and patient care.

Jamming the gears of a deadly virus

Team efforts at the School and beyond produce two potential treatments for COVID-19.

QBI probes three lethal coronaviruses to find possible drug targets

“This is looking across coronaviruses and finding the commonalities so we’re in a better position to attack SARS3 when it comes,” said Nevan Krogan, the director of QBI.

Update from the Dean: Back to school

Dean Guglielmo provides updates on ongoing efforts with science, education, and patient care in the School.

Nanobody-based antiviral developed at UCSF effectively blocks SARS-CoV-2 in the lab

School scientists developed an antiviral that fights SARS-CoV-2 that can be given as a nasal spray.

How targeting a key SARS-CoV-2 enzyme could lead to an antiviral drug

The chemical fragments could bind to and disable an enzyme that helps the virus replicate.

SARS-CoV-2 may spur growth of molecular “railways” out of infected cells, School scientists show

UCSF-led collaboration uncovers new avenues for COVID-19 drug discovery

School of Pharmacy serves as PPE distribution hub for community pharmacies

The School collaborates with the State of California and the California Pharmacists Association to provide vital PPE supplies to local pharmacies.

Update from the Dean: Confronting racism and health inequities

Our COVID-19 response: A commitment to anti-racist action

QBI Coronavirus Research Group identifies drugs that block SARS-CoV-2 in the laboratory

The QBI Coronavirus Research Group found six drugs that effectively beat back SARS-COV-2 in the laboratory.

Pages